[January 27, 2015]

Research and Markets: Organophosphate And Carbamate Poisoning Pipeline Insights Report 2015

Research and Markets (http://www.researchandmarkets.com/research/hcvj9w/organophosphate) has announced the addition of the "Organophosphate And Carbamate Poisoning-Pipeline Insights, 2014" subscription to their offering.

This Organophosphate And Carbamate Poisoning-Pipeline Insights report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Organophosphate And Carbamate Poisoning.

This report provides information on the therapeutic development based on the Organophosphate And Carbamate Poisoning dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and nknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information.

The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.

Key Topics Covered:

1. Organophosphate And Carbamate Poisoning Overview
2. Organophosphate And Carbamate Poisoning Pipeline Therapeutics
3. Organophosphate And Carbamate Poisoning Therapeutics under Development by Companies
4. Organophosphate And Carbamate Poisoning Late Stage Products (Filed and Phase III)
5. Comparative Analysis
6. Organophosphate And Carbamate Poisoning Mid Clinical Stage Products (Phase II)
7. Comparative Analysis
8. Organophosphate And Carbamate Poisoning Early Clinical Stage Products (Phase I and IND Filed)
9. Comparative Analysis
10. Organophosphate And Carbamate Poisoning Discovery and Pre-Clinical Stage Products
11. Comparative Analysis
12. Drug Candidate Profiles
13. Organophosphate And Carbamate Poisoning - Therapeutics Assessment
14. Assessment by Monotherapy Products
15. Assessment by Combination Products
16. Assessment by Route of Administration
17. Assessment by Molecule Type
18. Organophosphate And Carbamate Poisoning - Discontinued Products
19. Organophosphate And Carbamate Poisoning - Dormant Products
20. Companies Involved in Therapeutics Development for Organophosphate And Carbamate Poisoning
21. Appendix

For more information visit http://www.researchandmarkets.com/research/hcvj9w/organophosphate

[ Back To TMCnet.com's Homepage ]